Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q3 2019 (← Previous) (Next →)
Filing Date: Nov 14, 2019
Total Value: $1.643B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | TURNING POINT THERAPEUTICS I | 3,541,367 | $133M | 8.1% | $40.33 | — | COM | 90041T108 |
| — | MIRATI THERAPEUTICS INC | 1,600,000 | $125M | 7.6% | $38.92 | — | COM | 60468T105 |
| SPY | SPDR S&P 500 ETF TR | 400,000 | $119M | 7.2% | — | — | Put | 78462F103 |
| APLS | APELLIS PHARMACEUTICALS INC | 2,976,000 | $71.69M | 4.4% | $15.50 | +77.5% | COM | 03753U106 |
| — | REATA PHARMACEUTICALS INC | 819,769 | $65.82M | 4.0% | $55.95 | — | CL A | 75615P103 |
| BBIO | BRIDGEBIO PHARMA INC | 2,617,566 | $56.2M | 3.4% | $27.26 | +1.5% | COM | 10806X102 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 1,281,400 | $53.46M | 3.3% | $41.49 | — | COM | G11196105 |
| ASND | ASCENDIS PHARMA A S | 468,300 | $45.11M | 2.7% | $79.53 | — | SPONSORED ADR | 04351P101 |
| CRSP | CRISPR THERAPEUTICS AG | 1,084,300 | $44.45M | 2.7% | $39.27 | +21.7% | NAMEN AKT | H17182108 |
| — | MIRATI THERAPEUTICS INC | 550,000 | $42.85M | 2.6% | $38.92 | — | Put | 60468T105 |
| STOK | STOKE THERAPEUTICS INC | 1,788,394 | $38.43M | 2.3% | $26.85 | +3.8% | COM | 86150R107 |
| — | PRINCIPIA BIOPHARMA INC | 1,341,896 | $37.9M | 2.3% | $29.22 | — | COM | 74257L108 |
| — | BLUEPRINT MEDICINES CORP | 493,000 | $36.22M | 2.2% | $70.46 | — | COM | 09627Y109 |
| QURE | UNIQURE NV | 900,000 | $35.42M | 2.2% | $61.71 | -6.5% | SHS | N90064101 |
| — | ALLAKOS INC | 444,100 | $34.92M | 2.1% | $42.85 | — | COM | 01671P100 |
| — | TRICIDA INC | 1,082,880 | $33.43M | 2.0% | $33.32 | — | COM | 89610F101 |
| — | AXONICS MODULATION TECH INC | 1,222,671 | $32.91M | 2.0% | $15.11 | — | COM | 05465P101 |
| XBI | SPDR SERIES TRUST | 400,000 | $30.5M | 1.9% | — | — | Put | 78464A870 |
| — | QUOTIENT LTD | 3,642,000 | $28.3M | 1.7% | $8.95 | — | SHS | G73268107 |
| — | NEXTCURE INC | 884,600 | $27.29M | 1.7% | $14.98 | — | COM | 65343E108 |
| — | DECIPHERA PHARMACEUTICALS IN | 788,500 | $26.76M | 1.6% | $33.94 | — | COM | 24344T101 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 600,000 | $25.03M | 1.5% | $41.49 | — | Call | G11196105 |
| RCKT | ROCKET PHARMACEUTICALS INC | 2,123,760 | $24.74M | 1.5% | $16.47 | -24.7% | COM | 77313F106 |
| ASND | ASCENDIS PHARMA A S | 250,000 | $24.08M | 1.5% | $79.53 | — | Call | 04351P101 |
| — | MYOKARDIA INC | 443,000 | $23.1M | 1.4% | $17.38 | — | COM | 62857M105 |
| — | Y-MABS THERAPEUTICS INC | 883,800 | $23.03M | 1.4% | $25.33 | — | COM | 984241109 |
| GLPG | GALAPAGOS NV | 150,000 | $22.85M | 1.4% | $116.55 | — | SPON ADR | 36315X101 |
| ANAB | ANAPTYSBIO INC | 591,200 | $20.69M | 1.3% | $39.24 | +21.2% | COM | 032724106 |
| — | AMARIN CORP PLC | 1,332,000 | $20.19M | 1.2% | $15.29 | — | SPONS ADR NEW | 023111206 |
| — | EIDOS THERAPEUTICS INC | 540,686 | $19.45M | 1.2% | $21.18 | — | COM | 28249H104 |
| KURA | KURA ONCOLOGY INC | 1,231,500 | $18.68M | 1.1% | $14.56 | +22.3% | COM | 50127T109 |
| — | AKERO THERAPEUTICS INC | 740,621 | $16.85M | 1.0% | $19.15 | — | COM | 00973Y108 |
| SRPT | SAREPTA THERAPEUTICS INC | 221,700 | $16.7M | 1.0% | $127.51 | -7.4% | COM | 803607100 |
| TWST | TWIST BIOSCIENCE CORP | 687,149 | $16.41M | 1.0% | $22.16 | +31.2% | COM | 90184D100 |
| — | MIRATI THERAPEUTICS INC | 200,000 | $15.58M | 0.9% | $38.92 | — | Call | 60468T105 |
| ARGX | ARGENX SE | 128,110 | $14.6M | 0.9% | $82.17 | — | SPONSORED ADR | 04016X101 |
| — | NEKTAR THERAPEUTICS | 788,800 | $14.37M | 0.9% | $44.47 | — | COM | 640268108 |
| — | SATSUMA PHARMACEUTICALS INC | 858,382 | $12.88M | 0.8% | $15.01 | — | COM | 80405P107 |
| — | SAGE THERAPEUTICS INC | 88,700 | $12.44M | 0.8% | $161.07 | — | COM | 78667J108 |
| — | CHEMOCENTRYX INC | 1,820,000 | $12.34M | 0.8% | $13.89 | — | COM | 16383L106 |
| — | HEALTH SCIENCES ACQUISITN CORP | 1,080,000 | $11.59M | 0.7% | $10.60 | — | UNIT 04/01/2024 | 42227C201 |
| — | X4 PHARMACEUTICALS INC | 881,681 | $11.21M | 0.7% | $15.68 | — | COM | 98420X103 |
| INSP | INSPIRE MED SYS INC | 172,300 | $10.51M | 0.6% | $32.28 | +104.0% | COM | 457730109 |
| GOSS | GOSSAMER BIO INC | 618,129 | $10.38M | 0.6% | $20.85 | -4.6% | COM | 38341P102 |
| — | EIGER BIOPHARMACEUTICALS INC | 997,892 | $10.23M | 0.6% | $10.60 | — | COM | 28249U105 |
| ZLAB | ZAI LAB LTD | 277,161 | $8.966M | 0.5% | $22.58 | — | ADR | 98887Q104 |
| — | HARPOON THERAPEUTICS INC | 649,994 | $8.879M | 0.5% | $9.47 | — | COM | 41358P106 |
| — | AVROBIO INC | 568,294 | $8.024M | 0.5% | $21.11 | — | COM | 05455M100 |
| — | ORCHARD THERAPEUTICS PLC | 675,325 | $8.023M | 0.5% | $16.35 | — | ADS | 68570P101 |
| — | ARENA PHARMACEUTICALS INC | 172,300 | $7.886M | 0.5% | $42.46 | — | COM NEW | 040047607 |
| — | CONSTELLATION PHARMACEUTICAL I | 1,213,274 | $7.838M | 0.5% | $6.73 | — | COM | 210373106 |
| — | RA PHARMACEUTICALS INC | 295,600 | $6.991M | 0.4% | $18.20 | — | COM | 74933V108 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 479,988 | $5.961M | 0.4% | $31.47 | — | SPON ADS | 05280R100 |
| GNFTY | GENFIT S A | 300,000 | $5.223M | 0.3% | $24.00 | — | ADS | 372279109 |
| — | ATRECA INC | 406,142 | $4.971M | 0.3% | $18.84 | — | CL A COM | 04965G109 |
| — | MINERVA NEUROSCIENCES INC | 607,903 | $4.711M | 0.3% | $7.26 | — | COM | 603380106 |
| — | HOMOLOGY MEDICINES INC | 245,100 | $4.436M | 0.3% | $19.57 | — | COM | 438083107 |
| — | ATARA BIOTHERAPEUTICS INC | 300,000 | $4.236M | 0.3% | $39.75 | — | COM | 046513107 |
| — | PRECISION BIOSCIENCES INC | 467,518 | $3.922M | 0.2% | $17.95 | — | COM | 74019P108 |
| — | RUBIUS THERAPEUTICS INC | 491,700 | $3.86M | 0.2% | $21.38 | — | COM | 78116T103 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 39,300 | $3.541M | 0.2% | $31.24 | +199.0% | COM | 64125C109 |
| — | PHASEBIO PHARMACEUTICALS INC | 816,448 | $3.405M | 0.2% | $3.83 | — | COM | 717224109 |
| — | KEZAR LIFE SCIENCES INC | 927,869 | $3.043M | 0.2% | $17.30 | — | COM | 49372L100 |
| — | IGM BIOSCIENCES INC | 156,400 | $2.776M | 0.2% | $17.75 | — | COM | 449585108 |
| — | ITERUM THERAPEUTICS PLC | 396,385 | $2.339M | 0.1% | $10.89 | — | SHS | G6333L101 |
| — | ADVERUM BIOTECHNOLOGIES INC | 300,000 | $1.635M | 0.1% | — | — | Call | 00773U108 |
| — | AUDENTES THERAPEUTICS INC | 50,000 | $1.405M | 0.1% | $18.38 | — | COM | 05070R104 |
| SRRK | SCHOLAR ROCK HLDG CORP | 118,950 | $1.065M | 0.1% | $18.88 | -36.7% | COM | 80706P103 |
| — | G1 THERAPEUTICS INC | 1,000 | $1.025M | 0.1% | $1025.00 | — | COM | 3621LQ109 |
| — | ACCELERON PHARMA INC | 25,000 | $988K | 0.1% | $32.04 | — | COM | 00434H108 |
| IFRX | INFLARX NV | 300,000 | $741K | 0.0% | $27.44 | -89.4% | COM | N44821101 |
| — | ABEONA THERAPEUTICS INC | 200,000 | $452K | 0.0% | $8.20 | — | COM | 00289Y107 |
| ACRS | ACLARIS THERAPEUTICS INC | 250,000 | $270K | 0.0% | $19.94 | -92.9% | COM | 00461U105 |
| — | OUTLOOK THERAPEUTICS INC | 416,666 | $50,000 | 0.0% | $0.15 | — | *W EXP 02/18/202 | 69012T115 |
| — | OUTLOOK THERAPEUTICS INC | 15,753 | $23,000 | 0.0% | $2.03 | — | COM NEW | 69012T206 |